Literature DB >> 26055282

[Gastric perforation by MALT lymphoma. Case report].

José López-Zamudio1, Luis Ricardo Ramírez-González1, Julia Núñez-Márquez2, Clotilde Fuentes Orozco3, Alejandro González Ojeda3, Karla Lisseth Leonher-Ruezga4.   

Abstract

BACKGROUND: Gastric non-Hodgkin lymphoma is a rare tumour that represents approximately 7% of all stomach cancers and 2% of all lymphomas. The most frequent location of gastric MALT (mucosa associated lymphoid tissue) lymphomas is in the antrum in 41% of the cases, and 33% can be multifocal. The risk of spontaneous perforation of a gastric MALT lymphoma is 4-10%. CLINICAL CASE: 24 year old male patient carrying the Human Immunodeficiency Virus, who began with signs and symptoms of acute abdomen and fever 72 hours before arriving in the emergency room. A computed tomography was performed that showed free fluid in the cavity, and gastric wall thickening. The patient underwent a laparotomy, finding absence of the anterior wall of the stomach, sealed with the left lobe of the liver, colon and omentum. Total gastrectomy, with oesophagosty and jejunostomy tube, was performed.
CONCLUSIONS: Gastric perforation secondary to a MALT lymphoma is rare, with high mortality. There is limited information reported of this complication and should be highly suspected in order to provide appropriate treatment for a complication of this type.
Copyright © 2015 Academia Mexicana de Cirugía A.C. Published by Masson Doyma México S.A. All rights reserved.

Entities:  

Keywords:  Gastric lymphoma; Gastric neoplasms; Linfoma gástrico; Mucosa associated lymphoid tissue lymphoma; Tumor de tejido linfoide asociado a mucosas; Tumor gástrico

Mesh:

Year:  2015        PMID: 26055282     DOI: 10.1016/j.circir.2015.05.004

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  1 in total

1.  Gastric MALT lymphoma presented with primary perforation in an adolescent: a case report.

Authors:  Yu-Tang Chang; Ming-Yii Huang; Hsiang-Hung Shih; Chun-Chieh Wu; Tzu-Ying Lu; Pei-Chin Lin
Journal:  BMC Pediatr       Date:  2019-02-19       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.